These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 1658373

  • 1. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.
    Tsang SF, Wang F, Izumi KM, Kieff E.
    J Virol; 1991 Dec; 65(12):6765-71. PubMed ID: 1658373
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element.
    Wang F, Kikutani H, Tsang SF, Kishimoto T, Kieff E.
    J Virol; 1991 Aug; 65(8):4101-6. PubMed ID: 1649318
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
    Wang F, Tsang SF, Kurilla MG, Cohen JI, Kieff E.
    J Virol; 1990 Jul; 64(7):3407-16. PubMed ID: 2352328
    [Abstract] [Full Text] [Related]

  • 4. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.
    Reisman D, Sugden B.
    Mol Cell Biol; 1986 Nov; 6(11):3838-46. PubMed ID: 3025615
    [Abstract] [Full Text] [Related]

  • 5. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.
    Sung NS, Kenney S, Gutsch D, Pagano JS.
    J Virol; 1991 May; 65(5):2164-9. PubMed ID: 1850003
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E.
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation.
    Harada S, Kieff E.
    J Virol; 1997 Sep; 71(9):6611-8. PubMed ID: 9261383
    [Abstract] [Full Text] [Related]

  • 8. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
    Zimber-Strobl U, Kremmer E, Grässer F, Marschall G, Laux G, Bornkamm GW.
    EMBO J; 1993 Jan; 12(1):167-75. PubMed ID: 8381349
    [Abstract] [Full Text] [Related]

  • 9. The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.
    Tong X, Yalamanchili R, Harada S, Kieff E.
    J Virol; 1994 Oct; 68(10):6188-97. PubMed ID: 8083959
    [Abstract] [Full Text] [Related]

  • 10. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
    Laux G, Dugrillon F, Eckert C, Adam B, Zimber-Strobl U, Bornkamm GW.
    J Virol; 1994 Nov; 68(11):6947-58. PubMed ID: 7933076
    [Abstract] [Full Text] [Related]

  • 11. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.
    Harada S, Yalamanchili R, Kieff E.
    J Virol; 1998 Dec; 72(12):9948-54. PubMed ID: 9811732
    [Abstract] [Full Text] [Related]

  • 12. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Puglielli MT, Woisetschlaeger M, Speck SH.
    J Virol; 1996 Sep; 70(9):5758-68. PubMed ID: 8709191
    [Abstract] [Full Text] [Related]

  • 13. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
    Sjöblom A, Nerstedt A, Jansson A, Rymo L.
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
    [Abstract] [Full Text] [Related]

  • 14. Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes.
    Rooney CM, Brimmell M, Buschle M, Allan G, Farrell PJ, Kolman JL.
    J Virol; 1992 Jan; 66(1):496-504. PubMed ID: 1309259
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.
    Lin J, Johannsen E, Robertson E, Kieff E.
    J Virol; 2002 Jan; 76(1):232-42. PubMed ID: 11739688
    [Abstract] [Full Text] [Related]

  • 16. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
    Sauder C, Haiss P, Grässer FA, Zimber-Strobl U, Mueller-Lantzsch N.
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    Cohen JI, Wang F, Kieff E.
    J Virol; 1991 May; 65(5):2545-54. PubMed ID: 1850028
    [Abstract] [Full Text] [Related]

  • 18. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
    Ling PD, Hsieh JJ, Ruf IK, Rawlins DR, Hayward SD.
    J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain.
    Nitsche F, Bell A, Rickinson A.
    J Virol; 1997 Sep; 71(9):6619-28. PubMed ID: 9261384
    [Abstract] [Full Text] [Related]

  • 20. An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator.
    Cohen JI, Kieff E.
    J Virol; 1991 Nov; 65(11):5880-5. PubMed ID: 1656076
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.